• search
mRNA Synthesis IVT (In vitro Transcription) mRNA Synthesis IVT (In vitro Transcription)

mRNA Synthesis IVT (In vitro Transcription)

We provide customized, high-quality and scalable mRNA production by in vitro transcription (IVT).

The services are integrated with high-quality plasmid production and discovery scale mRNA LNP formulation.

We offer a customized synthesis of mRNA for screening to preclinical studies. Our high-quality mRNA transcripts are ideal for functional studies, therapeutics, diagnostics, and vaccine production. IVT is the method of choice to produce long and stable RNA molecules such as mRNA, guide RNA, SaRNA , or long RNA when chemical synthesis is not possible.

Irrespective of scale, mRNA molecules go through rigorous in-process and final quality checks through a set of standard and customized analytical methods. Our mRNA processes are flexible and can be customized as per client needs.

Our mRNA services are integrated to high-quality plasmid DNA production, processing enzymes, and other reagent generations. We provide high-throughput codon-optimized gene synthesis and cloning. We perform E. coli clone development, cell banking, E. coli fermentation, and plasmid purification.

mRNA formulation: We support small scale mRNA formulation development and characterization.

Speak to our experts

In vitro transcription

  • Sequence design, gene synthesis, and cloning
  • RNA transcripts from plasmids, PCR products, and cDNA
  • Conventional and Self-amplifying RNA (SaRNA)
  • Flexibility to choose transcriptional promoter (T7 or SP6)
  • Normal unmodified mRNA synthesis
  • Use of modified bases in mRNA transcripts (Pseudo UTP etc.)
  • Several strategies for 5’ capping such as co-translational capping with Anti Reverse Cap Analog (ARCA)
  • Post-translational vaccinia capping
  • Options to choose from Cap0 and Cap1
  • Template-derived poly A tail or enzymatic incorporation in the IVT mRNA template
  • Optimization of mRNA translation and stability

Purification

  • Well-characterized in RNAse free environment
  • High-quality plasmid purification, characterization, and IVT template preparation
  • Method optimization for gram quantity
  • Plasmid DNA purification and characterization
  • Purification using lithium chloride precipitation and chromatography

Analytical control

  • Batch-to-batch consistency of the IVT mRNA
  • Bioanalyzer
  • Purity (tape station)
  • Length confirmation
  • Sequence confirmation by cDNA
  • Capping efficiency by mass-spec
  • Endotoxin measurement
  • SE-HPLC
  • DOT-BLOT
  • Immunogenicity testing for vaccine candidates

Why Aurigene mRNA Services?

Customized screening and scaling up strategies

In vitro transcription, purification, and quality controls

Customized formulation

Modernized state-of-the-art facility

Adaptable, scalable and high-quality

Virtual Tour

 

Connect with our scientific experts for your drug discovery, development, and manufacturing needs

We understand that clear communication is essential to successful collaborations, and that's why we have a dedicated team that is always ready to help you. Whether you have questions about our services, want to discuss a potential partnership, or simply want to learn more about our company, we're here to help.

Our team of experts is dedicated to providing personalised solutions tailored to your unique needs. So, please don't hesitate to reach out to us. We look forward to hearing from you and helping you achieve your business goals.

Country

section

CAPTCHA
この質問はあなたが人間の訪問者であるかどうかをテストし、自動化されたスパム送信を防ぐためのものです。

rightCaptcha

寡核苷酸作为一种新型治疗方式

JULY 02, 2021

寡核苷酸作为一种新型治疗方式

寡核苷酸作为一种治疗类别是发现用于治疗人类疾病的新的重要治疗剂的革命性方法。基于 RNA 的干预有时适用于其他方式不起作用的情况。例如,它可能有助于治疗先天性新陈代谢错误、遗传疾病和罕见病 寡核苷酸疗法是将化学修饰的寡核苷酸用于治疗目的。寡核苷�...

Read More

Methoxy Polyethylene Glycol (m-PEGs)

Aurigene Pharmaceutical Services is a leader in the synthesis of activated MethoxyPolyethyleneGlycol(m-PEGs), With a comprehensive product range and customized services. ...

Read More

Base mediated spirocyclization of quinazoline: one-step synthesis of spiro-isoindolinone dihydroquinazolinones

2020

A novel approach for the spiro-isoindolinone dihydroquinazolinones has been demonstrated from 2- aminobenzamide and 2-cyanomethyl benzoate in the presence of KHMDS as a base to get moderate yields. The reaction has been screened in various bases followed by solvents and a gram scale reaction has also been executed under the given conditions. Based on the controll...

Read More
View All
×

You are about to leave Aurigene Pharmaceutical Services and affiliates website. Aurigene Pharmaceutical Services assumes no responsibility for the information presented on the external website or any further links from such sites. These links are presented to you only as a convenience, and the inclusion of any link does not imply endorsement by Aurigene Pharmaceutical Services.

If you wish to continue to this external website, click Proceed.

ProceedBack